Hospital Acquired Disease Testing Market Set to Record Exponential Growth by 2027

Transparency Market Research (TMR) has published a new report titled, ‘Hospital acquired disease testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global hospital acquired disease testing market was valued at US$ 798.6 Mn in 2018 and is projected to expand at a CAGR of 14.7% from 2019 to 2027. Overview Hospital acquired disease testing is used by health care professionals, especially by clinical laboratory technicians, for the diagnosis of nosocomial infection. The hospital acquired infection testing market has experienced strong growth in the last decade due to factors such as increased awareness about growth in the incidence of nosocomial infections globally and development of the innovative prevention and treatment solutions. Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=1759 Increase in Prevalence of Hospital Acquired Infections to Drive Market Demand for hospital acquired infection testing has increased due to high prevalence of hospital acquired infection globally. Therefore, several hospitals are focusing on expanding their in-house test menu. Without an active and widespread surveillance, identification of cultures of colonized nosocomial microorganisms would yield poor results. Better surveillance cultures enable the detection of unrecognized pathogen colonized patients and also assist in prevention of transmission of infections. Countries in Europe such as the Netherlands, Finland, and Denmark with active surveillance systems for nosocomial infection detection have been successful in controlling hospital acquired infection caused by pathogens such as MRSA, thereby stabilizing resistance rates. Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php? flag=CR&rep_id=1759 Urinary Tract Infection Segment to Dominate Market Based on test type, the global hospital acquired disease testing market has been divided into urinary tract, surgical site, pneumonia, bloodstream, MRSA, and others. Urinary tract infection is one of the most common infections with the highest prevalence globally, followed by surgical site infections. Other infections include respiratory, gastrointestinal, cardiovascular, bone, and joint-related infections. The global hospital acquired disease testing market is expanding at a promising rate owing to increasing prevalence of hospital-acquired infections, growing number of drug-resistant pathogens, and rising awareness among people regarding hospital-acquired diseases However, stringent regulations, guidance framework, and lack of budget and skilled labor in developing countries are expected to restrict the market growth during the forecast period Request for Analysis of COVID19 Impact on Hospital Acquired Disease Testing Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1759 North America to Dominate Global Market

Turn static files into dynamic content formats.

Create a flipbook